Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
- 2022
Available online from MWHC library: 1997 - present
English
0167-6806
10.1007/s10549-022-06613-4 [doi] 10.1007/s10549-022-06613-4 [pii]
Associate Dean for Research Development
MedStar Health
Published Erratum
Available online from MWHC library: 1997 - present
English
0167-6806
10.1007/s10549-022-06613-4 [doi] 10.1007/s10549-022-06613-4 [pii]
Associate Dean for Research Development
MedStar Health
Published Erratum